fluconazole has been researched along with Central Hypothyroidism in 2 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Twelve risk factors for dTSH were identified on univariate analysis: cesarean section, mechanical ventilation, patent ductus arteriosus (PDA), pneumothorax, and administration of cefotaxime, vancomycin, fluconazole, dopamine, ibuprofen, furosemide, insulin, and packed red blood cells." | 3.85 | Risk Factors for the Development of Delayed TSH Elevation in Neonatal Intensive Care Unit Newborns. ( Almashanu, S; Bier Palmon, R; Eventov-Friedman, S; Flidel-Rimon, O; Golan, A; Kats, N; Keidar, R; Marom, R; Troitzky, M; Zung, A, 2017) |
| "The extent of potential pharmacokinetic drug-drug interactions affecting anticancer agents disposition has not been specifically investigated." | 1.35 | Potential pharmacokinetic interactions affecting antitumor drug disposition in cancer patients. ( Beretz, L; Bergerat, JP; Lemachatti, J; Levêque, D, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zung, A | 1 |
| Bier Palmon, R | 1 |
| Golan, A | 1 |
| Troitzky, M | 1 |
| Eventov-Friedman, S | 1 |
| Marom, R | 1 |
| Keidar, R | 1 |
| Kats, N | 1 |
| Almashanu, S | 1 |
| Flidel-Rimon, O | 1 |
| Lemachatti, J | 1 |
| Levêque, D | 1 |
| Beretz, L | 1 |
| Bergerat, JP | 1 |
2 other studies available for fluconazole and Central Hypothyroidism
| Article | Year |
|---|---|
Risk Factors for the Development of Delayed TSH Elevation in Neonatal Intensive Care Unit Newborns.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Cefotaxime; Cesar | 2017 |
Potential pharmacokinetic interactions affecting antitumor drug disposition in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cardiovascular Diseases; Comorbidity; Cytochr | 2009 |